Cite
HARVARD Citation
Dutour, A. et al. (2016). Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy. Diabetes, obesity & metabolism. 18 (9), pp. 882-891. [Online].